CRBP 10-Q: SEC filing
Corbus Pharmaceuticals
Filed with the SEC on · accession 0001193125-26-455614
CRBP filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +11.6% by the first close after the filing.
Summary of the filing
Corbus Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results and operational updates for its clinical-stage drug development programs including CRB-601 and CRB-913.
Key details
How CRBP stock reacted
Close before
$3.52
Nov 9, 2026
First close after
+11.65%
$3.93
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CRBP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CRBP?
Click hereFrequently asked questions
What did CRBP file with the SEC on Nov 10, 2026?
CRBP filed a 10-Q (SEC filing). Corbus Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results and operational updates for its clinical-stage drug development programs including CRB-601 and CRB-913.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did CRBP stock react to this filing?
CRBP closed at $3.52 before the filing and $3.93 on Nov 10, 2026 (+11.65%).
Other CRBP SEC filings
- 8-K · SEC filingNov 10, 2026
- SCHEDULE 13G/A · SEC filingNov 2, 2026
- SCHEDULE 13G/A · SEC filingOct 29, 2026
- 8-K · SEC filingOct 15, 2026
- SCHEDULE 13G · SEC filingSep 30, 2026
- 8-K · Fda approvalSep 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 424B5 · Secondary offeringAug 7, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · SEC filingAug 6, 2026
Get alerts when CRBP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days